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In this issue, Meng and coworkers show that the multi-functional protein LDL
receptor-related protein-1 (LRP1) predicts favorable outcomes in patients with
lung adenocarcinoma. LRP1 is expressed predominantly in stromal cells of
both lung squamous cell carcinomas (shown in the cover image) and
adenocarcinomas. The investigators show that transcellular actions of LRP1
inhibit cancer cell growth, suggesting that stromal cells expressing LRP1
improve clinical outcomes. For further details, please see Meng and colleagues
on page 2426 in this issue.
The Journal of Clinical and Translational Research vii www.aacrjournals.org
